Inflammatory bowel disease in Indonesian children
Keywords:
Inflammatory bowel disease, Indonesian children
Abstract
Inflammatory bowel disease (IBD) is a term usedto describe two disorders associated with
gastrointestinal inflammation: Crohn’s disease
(CD) and ulcerative colitis (UC). The incidence
of IBD is higher in developed countries, while there is
unpublished data of pediatric IBD in Indonesia.
Clinical manifestations of IBD vary, consist of
gastrointestinal (such as diarrhea and abdominal pain)
and extraintestinal manifestations. Definite diagnosis
of IBD is based on endoscopy and histopathology. The
management includes pharmacotherapy, nutrition,
surgery, and psychotherapy. This disorder has a high
recurrence rate, where CD’s recurrence rate is higher
than UC.1,2
References
1. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and
pathophysiology of inflammatory bowel disease. Clin
Microbiol Rev 2002;15:79-94.
2. Hyams JS. Inflammatory bowel disease. Pediatr Rev
2005;26:314-20.
3. O’Gorman M, Lake AM. Chronic inflammatory bowel disease
in childhood. Pediatr Rev 1993;14:475-80.
4. Hyams JS. Inflammatory bowel disease. Pediatr Rev 2000;
21:291-5.
5. Rowe WA. Inflammatory bowel disease. Emedicine. Accessed
on 2007 March 8. Available from www.emedicine.com.
6. Jenkins HR. Inflammatory bowel disease. Arch Dis Child
2001;85:435-7.
7. Podolsky DK. Inflammatory bowel disease. N Engl J Med
2002;347:417-29.
8. Barnias G, Nyce MR, De La Rue SA, Cominelli F. New
concepts in the pathophysiology of inflammatory bowel
disease. Ann Intern Med 2005;143:895-904.
9. Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas
A, et al. Association of extraintestinal manifestations of
inflammatory bowel disease in a province of western Hungary
with disease phenotype: results of a 25-year follow up study.
World J Gastroenterol 2003;9:2300-7.
10. Canani RB, de Horatio LT, Terrin G, Romano MT, Miele E,
Staiano A, et al. Combined use of noninvasive tests is useful
in the initial diagnostic approach to a child with suspected
inflammatory bowel disease. J Pediatr Gastroenterol Nutr
2006;42:9-15.
11. Sabery N, Bass D. Use of serologic markers as a screening
tool in inflammatory bowel disease compared with elevated
erythrocyte sedimentation rate and anemia. Pediatrics
2007;119:e193-9.
12. IBD Working Group of the European Society for Paediatric
Gastroenterology, Hepatology and Nutrition (ESPGHAN).
Inflammatory bowel disease in children and adolescents:
recommendations for diagnosis- the Porto Criteria. J Pediatr
Gastroenterol Nutr 2005;41:1-7.
13. Abdullah BA, Gupta SK, Croffie JM, Pfefferkorn MD, Molleston
JP, Corkins MR, et al. The role of esophagogastroduodenoscopy
in the initial evaluation of childhood inflammatory bowel disease:
a 7-year study. J Pediatr Gastroenterol Nutr 2002;35:636-40.
14. Nayar M, Rhodes JM.Management of inflammatory bowel
disease. Postgrad Med J 2004;80:206-13.
15. Shapiro W. Inflammatory bowel disease. Accessed on 2007
March 8. Available from www.emedicine.com.
16. Sutherland L, MacDonald JK. Oral 5-aminosalicylic acid for
induction of remission in ulcerative colitis. Cochrane
Database of Systematic Reviews 2006, Issue 2. Art. No.:
CD000543. DOI: 10.1002/14651858.CD000543.pub2.
17. Timmer A, McDonald JWD, MacDonald JK. Azathioprine
and 6-mercaptopurine for maintenance of remission in
ulcerative colitis. Cochrane Database of Systematic Reviews
2007, Issue 1. Art. No.: CD000478. DOI: 10.1002/
14651858.CD000478.pub2.
18. Lawson MM, Thomas AG, Akobeng AK. Tumour necrosis
factor alpha blocking agents for induction of remission in
ulcerative colitis. Cochrane Database of Systematic Reviews
2006, Issue 3. Art. No.: CD005112. DOI: 10.1002/
14651858.CD005112.pub2.
19. Jonkers D, Stockbrûgger R. Probiotics and inflammatory
bowel disease. J R Soc Med 2003;96:167-71.
20. Heuschkel RB, Menache CC, Megerian JT. Enteral nutrition
and corticosteroids in the treatment of acute Crohn’s disease
in children. J Pediatr Gastroenterol Nutr 2000;31:8-15.
21. Hanauer SB. Inflammatory bowel disease. N Engl J Med
1996;334:841-8.
22. Walker-Smith JA. Chronic inflammatory bowel disease in
children: a complex problem in management. Postgrad Med
J 2000;76:469-72.
23. Mascarenhas MR, Altschuler SM. Treatment of inflammatory
bowel disease. Pediatr Rev 1997;18:95-8.
24. Zachos M, Tondeur M, Griffiths AM. Enteral nutrition
therapy for induction of remission in Crohn’s disease.
Cochrane Database Syst Rev 2007, Issue 1. Art. No.:
CD000542. DOI: 10.1002/14651858.CD000542.pub2.
25. MacDonald A. Omega-3 fatty acids as adjunctive therapy in
Crohns disease. Gastroenterol Nurs 2006;29:295-301.
26. Engstrom I. Inflammatory bowel disease in children and
adolescents: mental health and family functioning. J Pediatr
Gastroenterol Nutr 1999;28:S28-33.
27. Ekbom A, Helmick GC, Zack M, Holmberg L, Adami HO.
Survival and cause of death in patients with inflammatory
bowel disease: a population based study. Gastroenterology
1992;103:954-60.
pathophysiology of inflammatory bowel disease. Clin
Microbiol Rev 2002;15:79-94.
2. Hyams JS. Inflammatory bowel disease. Pediatr Rev
2005;26:314-20.
3. O’Gorman M, Lake AM. Chronic inflammatory bowel disease
in childhood. Pediatr Rev 1993;14:475-80.
4. Hyams JS. Inflammatory bowel disease. Pediatr Rev 2000;
21:291-5.
5. Rowe WA. Inflammatory bowel disease. Emedicine. Accessed
on 2007 March 8. Available from www.emedicine.com.
6. Jenkins HR. Inflammatory bowel disease. Arch Dis Child
2001;85:435-7.
7. Podolsky DK. Inflammatory bowel disease. N Engl J Med
2002;347:417-29.
8. Barnias G, Nyce MR, De La Rue SA, Cominelli F. New
concepts in the pathophysiology of inflammatory bowel
disease. Ann Intern Med 2005;143:895-904.
9. Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas
A, et al. Association of extraintestinal manifestations of
inflammatory bowel disease in a province of western Hungary
with disease phenotype: results of a 25-year follow up study.
World J Gastroenterol 2003;9:2300-7.
10. Canani RB, de Horatio LT, Terrin G, Romano MT, Miele E,
Staiano A, et al. Combined use of noninvasive tests is useful
in the initial diagnostic approach to a child with suspected
inflammatory bowel disease. J Pediatr Gastroenterol Nutr
2006;42:9-15.
11. Sabery N, Bass D. Use of serologic markers as a screening
tool in inflammatory bowel disease compared with elevated
erythrocyte sedimentation rate and anemia. Pediatrics
2007;119:e193-9.
12. IBD Working Group of the European Society for Paediatric
Gastroenterology, Hepatology and Nutrition (ESPGHAN).
Inflammatory bowel disease in children and adolescents:
recommendations for diagnosis- the Porto Criteria. J Pediatr
Gastroenterol Nutr 2005;41:1-7.
13. Abdullah BA, Gupta SK, Croffie JM, Pfefferkorn MD, Molleston
JP, Corkins MR, et al. The role of esophagogastroduodenoscopy
in the initial evaluation of childhood inflammatory bowel disease:
a 7-year study. J Pediatr Gastroenterol Nutr 2002;35:636-40.
14. Nayar M, Rhodes JM.Management of inflammatory bowel
disease. Postgrad Med J 2004;80:206-13.
15. Shapiro W. Inflammatory bowel disease. Accessed on 2007
March 8. Available from www.emedicine.com.
16. Sutherland L, MacDonald JK. Oral 5-aminosalicylic acid for
induction of remission in ulcerative colitis. Cochrane
Database of Systematic Reviews 2006, Issue 2. Art. No.:
CD000543. DOI: 10.1002/14651858.CD000543.pub2.
17. Timmer A, McDonald JWD, MacDonald JK. Azathioprine
and 6-mercaptopurine for maintenance of remission in
ulcerative colitis. Cochrane Database of Systematic Reviews
2007, Issue 1. Art. No.: CD000478. DOI: 10.1002/
14651858.CD000478.pub2.
18. Lawson MM, Thomas AG, Akobeng AK. Tumour necrosis
factor alpha blocking agents for induction of remission in
ulcerative colitis. Cochrane Database of Systematic Reviews
2006, Issue 3. Art. No.: CD005112. DOI: 10.1002/
14651858.CD005112.pub2.
19. Jonkers D, Stockbrûgger R. Probiotics and inflammatory
bowel disease. J R Soc Med 2003;96:167-71.
20. Heuschkel RB, Menache CC, Megerian JT. Enteral nutrition
and corticosteroids in the treatment of acute Crohn’s disease
in children. J Pediatr Gastroenterol Nutr 2000;31:8-15.
21. Hanauer SB. Inflammatory bowel disease. N Engl J Med
1996;334:841-8.
22. Walker-Smith JA. Chronic inflammatory bowel disease in
children: a complex problem in management. Postgrad Med
J 2000;76:469-72.
23. Mascarenhas MR, Altschuler SM. Treatment of inflammatory
bowel disease. Pediatr Rev 1997;18:95-8.
24. Zachos M, Tondeur M, Griffiths AM. Enteral nutrition
therapy for induction of remission in Crohn’s disease.
Cochrane Database Syst Rev 2007, Issue 1. Art. No.:
CD000542. DOI: 10.1002/14651858.CD000542.pub2.
25. MacDonald A. Omega-3 fatty acids as adjunctive therapy in
Crohns disease. Gastroenterol Nurs 2006;29:295-301.
26. Engstrom I. Inflammatory bowel disease in children and
adolescents: mental health and family functioning. J Pediatr
Gastroenterol Nutr 1999;28:S28-33.
27. Ekbom A, Helmick GC, Zack M, Holmberg L, Adami HO.
Survival and cause of death in patients with inflammatory
bowel disease: a population based study. Gastroenterology
1992;103:954-60.
Published
2016-09-24
How to Cite
1.
Hegar B, Ananta Y, Rini D. Inflammatory bowel disease in Indonesian children. PI [Internet]. 24Sep.2016 [cited 2Dec.2024];47(6):307-2. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/437
Section
Case Report
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Received 2016-09-02
Accepted 2016-09-02
Published 2016-09-24
Accepted 2016-09-02
Published 2016-09-24
